Knight Therapeutics Inc.
KHTRF
$3.79
-$0.0965-2.48%
| Weiss Ratings | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.34 | |||
| Price History | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.91% | |||
| 30-Day Total Return | -4.38% | |||
| 60-Day Total Return | 0.15% | |||
| 90-Day Total Return | -6.18% | |||
| Year to Date Total Return | 5.00% | |||
| 1-Year Total Return | -4.56% | |||
| 2-Year Total Return | 1.00% | |||
| 3-Year Total Return | -10.18% | |||
| 5-Year Total Return | -20.92% | |||
| 52-Week High % Change | -14.57% | |||
| 52-Week Low % Change | 11.70% | |||
| Price | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.55 | |||
| 52-Week Low Price | $3.48 | |||
| 52-Week Low Price (Date) | Feb 03, 2025 | |||
| 52-Week High Price (Date) | Sep 16, 2024 | |||
| Valuation | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 381.99M | |||
| Enterprise Value | 300.06M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.22 | |||
| Earnings Per Share Growth | 388.40% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.53 | |||
| Price/Book (Q) | 0.69 | |||
| Enterprise Value/Revenue (TTM) | 1.17 | |||
| Price | $3.79 | |||
| Enterprise Value/EBITDA (TTM) | 7.12 | |||
| Enterprise Value/EBIT | 39.77 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 101.13M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 514 484 4483 | |||
| Address | 3400 de Maisonneuve Boulevard West Montreal, QC H3Z 3B8 | |||
| Website | www.knighttx.com | |||
| Country | Canada | |||
| Year Founded | 2013 | |||
| Profitability | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 2.94% | |||
| Profit Margin | -8.82% | |||
| Management Effectiveness | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.65% | |||
| Return on Equity | -- | |||
| Income Statement | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 256.26M | |||
| Total Revenue (TTM) | 256.26M | |||
| Revenue Per Share | $2.53 | |||
| Gross Profit (TTM) | 123.68M | |||
| EBITDA (TTM) | 42.16M | |||
| EBIT (TTM) | 7.54M | |||
| Net Income (TTM) | -22.61M | |||
| Net Income Avl. to Common (TTM) | -22.61M | |||
| Total Revenue Growth (Q YOY) | 11.33% | |||
| Earnings Growth (Q YOY) | -99.13% | |||
| EPS Diluted (TTM) | -0.22 | |||
| EPS Diluted Growth (Q YOY) | -99.11% | |||
| Balance Sheet | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 127.55M | |||
| Cash Per Share (Q) | $1.26 | |||
| Total Current Assets (Q) | 294.29M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 572.86M | |||
| Current Ratio (Q) | 3.365 | |||
| Book Value Per Share (Q) | $5.67 | |||
| Total Assets (Q) | 712.31M | |||
| Total Current Liabilities (Q) | 87.46M | |||
| Total Debt (Q) | 43.09M | |||
| Total Liabilities (Q) | 139.45M | |||
| Total Common Equity (Q) | 572.86M | |||
| Cash Flow | KHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.43M | |||
| Cash from Financing (TTM) | -39.57M | |||
| Net Change in Cash (TTM) | -2.68M | |||
| Levered Free Cash Flow (TTM) | 33.81M | |||
| Cash from Operations (TTM) | 38.98M | |||
